CYTEK BIOSCIENCES, INC. Investment Income, Interest
CYTEK BIOSCIENCES, INC. (CTKB) reported Investment Income, Interest of $819.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. investment income, interest for the quarter ending 2026-06-30 was $819.00K, a 47.57% increase year-over-year.
- CYTEK BIOSCIENCES, INC. investment income, interest for the quarter ending 2026-03-31 was $787.00K, a 54.92% increase year-over-year.
- CYTEK BIOSCIENCES, INC. investment income, interest for the quarter ending 2025-12-31 was $580.00K, a 36.47% decline year-over-year.
- CYTEK BIOSCIENCES, INC. investment income, interest for the quarter ending 2025-09-30 was $573.00K, a 60.01% decline year-over-year.
- CYTEK BIOSCIENCES, INC. investment income, interest for fiscal 2025 was $2.22M, a 56.73% decline from fiscal 2024.
- CYTEK BIOSCIENCES, INC. investment income, interest for fiscal 2024 was $5.12M, a 20.15% decline from fiscal 2023.
- CYTEK BIOSCIENCES, INC. investment income, interest for fiscal 2023 was $6.41M, a 38.84% increase from fiscal 2022.
- CYTEK BIOSCIENCES, INC. investment income, interest for fiscal 2022 was $4.62M, a 9326.53% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $819.00K 10-Q · filed 2026-08-05 | $1.61M 10-Q · filed 2026-08-05 | $2.19M derived: sum of 3 quarters · filed 2026-08-05 | $2.76M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $787.00K 10-Q · filed 2026-05-07 | $1.37M derived: sum of 2 quarters · filed 2026-05-07 | $1.94M derived: sum of 3 quarters · filed 2026-05-07 | $2.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $580.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.15M derived: sum of 2 quarters · filed 2026-02-26 | $1.71M derived: sum of 3 quarters · filed 2026-08-05 | $2.22M 10-K · filed 2026-02-26 |
| 2025-09-30 | $573.00K 10-Q · filed 2025-11-05 | $1.13M derived: sum of 2 quarters · filed 2026-08-05 | $1.64M 10-Q · filed 2025-11-05 | $2.55M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $555.00K 10-Q · filed 2026-08-05 | $1.06M 10-Q · filed 2026-08-05 | $1.98M derived: sum of 3 quarters · filed 2026-08-05 | $3.41M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $508.00K 10-Q · filed 2026-05-07 | $1.42M derived: sum of 2 quarters · filed 2026-05-07 | $2.85M derived: sum of 3 quarters · filed 2026-05-07 | $4.27M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $913.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.35M derived: sum of 2 quarters · filed 2026-02-26 | $3.76M derived: sum of 3 quarters · filed 2026-02-26 | $5.12M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.43M 10-Q · filed 2025-11-05 | $2.85M derived: sum of 2 quarters · filed 2025-11-05 | $4.21M 10-Q · filed 2025-11-05 | $5.66M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $1.42M 10-Q · filed 2025-08-06 | $2.77M 10-Q · filed 2025-08-06 | $4.22M derived: sum of 3 quarters · filed 2026-02-26 | $5.84M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.36M 10-Q · filed 2025-05-08 | $2.81M derived: sum of 2 quarters · filed 2026-02-26 | $4.43M derived: sum of 3 quarters · filed 2026-02-26 | $5.63M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.07M derived: sum of 2 quarters · filed 2026-02-26 | $4.27M derived: sum of 3 quarters · filed 2026-02-26 | $6.41M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.62M 10-Q · filed 2024-11-07 | $2.82M derived: sum of 2 quarters · filed 2024-11-07 | $4.96M 10-Q · filed 2024-11-07 | $7.59M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $1.20M 10-Q · filed 2024-08-06 | $3.34M 10-Q · filed 2024-08-06 | $5.97M derived: sum of 3 quarters · filed 2025-02-28 | $7.55M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $2.14M 10-Q · filed 2024-05-08 | $4.77M derived: sum of 2 quarters · filed 2025-02-28 | $6.35M derived: sum of 3 quarters · filed 2025-02-28 | $6.74M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $4.21M derived: sum of 2 quarters · filed 2025-02-28 | $4.60M derived: sum of 3 quarters · filed 2025-02-28 | $4.62M 10-K · filed 2025-02-28 |
| 2022-09-30 | $1.58M 10-Q · filed 2023-11-14 | $1.98M derived: sum of 2 quarters · filed 2023-11-14 | $1.99M 10-Q · filed 2023-11-14 | $2.01M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-06-30 | $391.00K 10-Q · filed 2023-08-08 | $409.00K 10-Q · filed 2023-08-08 | $427.00K derived: sum of 3 quarters · filed 2024-03-13 | $439.00K derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | $18.00K 10-Q · filed 2023-05-09 | $36.00K derived: sum of 2 quarters · filed 2024-03-13 | $48.00K derived: sum of 3 quarters · filed 2024-03-13 | $57.00K derived: sum of 4 quarters · filed 2024-03-13 |
| 2021-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $30.00K derived: sum of 2 quarters · filed 2024-03-13 | $39.00K derived: sum of 3 quarters · filed 2024-03-13 | $49.00K 10-K · filed 2024-03-13 |
| 2021-09-30 | $12.00K 10-Q · filed 2022-11-09 | $21.00K derived: sum of 2 quarters · filed 2022-11-09 | $31.00K 10-Q · filed 2022-11-09 | $36.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $9.00K 10-Q · filed 2022-08-10 | $19.00K 10-Q · filed 2022-08-10 | $24.00K derived: sum of 3 quarters · filed 2023-03-01 | $27.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $10.00K 10-Q · filed 2022-05-12 | $15.00K derived: sum of 2 quarters · filed 2023-03-01 | $18.00K derived: sum of 3 quarters · filed 2023-03-01 | $34.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $8.00K derived: sum of 2 quarters · filed 2023-03-01 | $24.00K derived: sum of 3 quarters · filed 2023-03-01 | $110.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $3.00K 10-Q · filed 2021-11-12 | $19.00K derived: sum of 2 quarters · filed 2021-11-12 | $105.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $16.00K 10-Q · filed 2021-09-03 | $102.00K 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |